Ovulation Disorders: Types, Testing, and Treatment

If you have been told you have an ovulation disorder, or if you suspect something is not right with your cycles, you are probably feeling a mix of concern and confusion. What does it mean when your body does not ovulate properly? Why is this happening? And most importantly, can it be fixed?

The good news is that ovulation disorders are among the most treatable causes of infertility. Once the underlying issue is identified, treatment is often highly effective. Many women with ovulation problems go on to conceive, sometimes with relatively simple interventions.

This guide will help you understand the different types of ovulation disorders, how they are diagnosed, and what treatment options are available. Knowledge is the first step toward finding a solution that works for you.

What Is Ovulation and Why Does It Matter?

Ovulation is the release of a mature egg from one of your ovaries. It is the central event in your menstrual cycle and is essential for natural conception.

In a healthy cycle, hormonal signals from your brain stimulate your ovaries to develop follicles, each containing an egg. One follicle becomes dominant and continues growing while the others regress. When the dominant follicle reaches maturity, a surge of luteinising hormone (LH) triggers the release of the egg.

The released egg travels into the fallopian tube, where it can be fertilised if sperm are present. If ovulation does not occur, there is no egg available for fertilisation, and pregnancy cannot happen naturally that cycle.

Types of Ovulation Disorders

The World Health Organisation classifies ovulation disorders into three main groups based on their underlying cause. For a complete overview of fertility-related conditions, visit our conditions guide.

Group 1: Hypothalamic-Pituitary Failure

In these disorders, the problem originates in the brain. The hypothalamus and pituitary gland, which normally send hormonal signals to stimulate the ovaries, are not functioning properly.

Characteristics

Women with Group 1 disorders typically have low levels of both FSH (follicle-stimulating hormone) and estrogen. Periods are usually absent or very infrequent.

Causes

Hypothalamic amenorrhea is often caused by excessive exercise, very low body weight, or significant stress. The body essentially decides that conditions are not suitable for pregnancy and shuts down reproductive function. Eating disorders are a common underlying factor. Less commonly, pituitary tumours or other pituitary conditions can disrupt hormone production.

Treatment Approach

Treatment focuses on addressing the underlying cause. NICE advises that reaching a healthy weight (if your BMI is under 18.5) and moderating very high exercise levels may help restore regular ovulation. When this is not enough, or not the cause, NICE recommends ovulation induction with gonadotropins that include LH activity, or with pulsatile GnRH (gonadotropin-releasing hormone).

Group 2: Hypothalamic-Pituitary Dysfunction

This is the most common category of ovulation disorders. The hormonal signalling system is present but dysfunctional.

Characteristics

Women in this group typically have normal or elevated estrogen levels and variable FSH levels. Cycles may be irregular, and ovulation may occur inconsistently.

The Most Common Cause: PCOS

Polycystic ovary syndrome (PCOS) is by far the most common cause of Group 2 ovulation disorders. Women with PCOS often have elevated androgens (male hormones), insulin resistance, and multiple small follicles on their ovaries that fail to develop to maturity.

Worldwide, PCOS affects an estimated 10 to 13 percent of women of reproductive age, and the 2023 international guideline notes it may be more common in the Eastern Mediterranean region, which includes the UAE. Local estimates vary widely depending on how the studies were done.

Other Causes

Raised prolactin (hyperprolactinaemia) and thyroid disorders can also stop ovulation. They are usually considered separately from the three WHO groups because they have their own specific treatments.

Treatment Approach

For PCOS, treatment often begins with lifestyle modifications, particularly weight loss if overweight. Letrozole is the recommended first-line ovulation induction medicine under the 2023 international PCOS guideline, with clomiphene (alone or with metformin) as an alternative. If these do not work, injectable gonadotropins, laparoscopic ovarian surgery or IVF may be recommended. Learn more about PCOS treatment options.

For hyperprolactinaemia, NICE recommends cabergoline, which lowers prolactin levels and often restores ovulation. For thyroid disorders, treating the thyroid problem typically normalises ovulation.

Group 3: Ovarian Failure

In these disorders, the ovaries themselves are not functioning properly, either due to depleted egg supply or ovarian damage.

Characteristics

Women with ovarian failure have high FSH levels (the brain is trying hard to stimulate the ovaries) and low estrogen levels (the ovaries are not responding).

Causes

Primary ovarian insufficiency (POI), formerly called premature ovarian failure, occurs when the ovaries stop functioning before age 40. Causes include genetic factors, autoimmune conditions, chemotherapy or radiation, and surgical removal of ovarian tissue. In many cases, the cause is unknown.

Treatment Approach

Unfortunately, ovarian failure is the most challenging ovulation disorder to treat. Ovulation induction medications are typically ineffective because the issue is the ovaries themselves, not the hormonal signalling.

Treatment options include donor eggs for women who wish to carry a pregnancy (egg donation is not permitted in the UAE, so this means treatment abroad), or adoption and other paths to parenthood. In rare cases, women with POI may have intermittent ovarian function and spontaneous pregnancy.

Signs You May Have an Ovulation Disorder

Several signs may suggest you are not ovulating regularly.

Irregular Periods

Cycles that vary significantly in length (more than 7 to 9 days of variation), cycles consistently shorter than 21 days or longer than 35 days, or unpredictable periods may indicate irregular ovulation.

Absent Periods

If you are not having periods at all (and are not pregnant, breastfeeding, or on certain contraceptives), you are likely not ovulating.

Very Light or Very Short Periods

Extremely light periods or periods lasting only a day or two may indicate anovulation or hormonal imbalances.

Lack of Typical Cycle Symptoms

Many women notice changes throughout their cycle, such as cervical mucus changes around ovulation or breast tenderness before their period. If your cycles feel the same throughout, you may not be ovulating.

Difficulty Conceiving

If you have been trying to conceive for 12 months (or 6 months if over 35) without success, an ovulation disorder may be contributing.

Diagnosis: How Ovulation Disorders Are Identified

Several tests help determine whether you are ovulating and identify the underlying cause.

Blood Tests

FSH and LH

Measured early in your cycle (days 2 to 4), these hormones help categorise the type of ovulation disorder.

Estradiol

Also measured early in the cycle, estradiol provides additional information about ovarian function.

Progesterone

Measured about a week before your expected period (day 21 in a 28-day cycle, or later if your cycles are longer), progesterone confirms whether ovulation occurred. A raised level indicates ovulation happened. If your cycles are long and irregular, the test may need to be repeated weekly until your next period.

AMH

Anti-Mullerian hormone provides information about ovarian reserve and can help identify ovarian failure.

Thyroid Function Tests

Thyroid disorders are a treatable cause of ovulation problems. NICE recommends checking thyroid function if you have symptoms of thyroid disease.

Prolactin

Elevated prolactin can suppress ovulation.

Androgens

Testosterone and other androgens may be elevated in PCOS.

Ultrasound

Transvaginal ultrasound can visualise the ovaries and identify polycystic ovarian morphology (multiple small follicles), the presence or absence of developing follicles, and other ovarian abnormalities.

Cycle Monitoring

Ovulation predictor kits or serial ultrasounds can provide information about whether and when ovulation occurs. Basal body temperature charts are not recommended for confirming ovulation, because NICE notes they do not reliably predict it.

Treatment Options

Treatment depends on the underlying cause and your goals.

Lifestyle Modifications

For women with PCOS or hypothalamic amenorrhea, lifestyle changes may be the first step.

Weight Management

In women with PCOS who have excess weight, losing 5 to 10 percent of body weight can bring significant improvements, including more regular ovulation in some cases.

Addressing Energy Deficiency

For women with hypothalamic amenorrhea due to low weight or excessive exercise, increasing caloric intake and reducing exercise intensity can restore hormonal function.

Ovulation Induction Medications

These fertility medications stimulate the ovaries to develop and release eggs.

Letrozole (Femara)

Recommended as the first-line treatment for PCOS-related anovulation by the 2023 international PCOS guideline, letrozole works by temporarily blocking estrogen production, which stimulates FSH release and follicle development. Its use for fertility is off-label in many countries.

Clomiphene Citrate (Clomid)

The traditional first-line medication, clomiphene blocks estrogen receptors in the brain, leading to increased FSH production.

Gonadotropins

Injectable FSH and LH directly stimulate the ovaries. These are used when oral medications are ineffective or for women with hypothalamic-pituitary failure.

Treating Underlying Conditions

Thyroid Medication

Restoring normal thyroid function typically resolves ovulation problems caused by thyroid disorders.

Dopamine Agonists

Cabergoline (recommended by NICE over the older bromocriptine) lowers prolactin levels and restores ovulation in many women with hyperprolactinaemia.

Metformin

For women with PCOS, metformin may improve ovulation and pregnancy rates, although it is less effective than letrozole or clomiphene; it is sometimes combined with clomiphene.

Assisted Reproduction

When simpler treatments do not work, IUI or IVF may be recommended. IVF is particularly useful when multiple treatment cycles have failed or when other fertility factors are present.

Success Rates

The good news is that ovulation disorders generally respond well to treatment.

For women with PCOS, letrozole performs better than clomiphene. In the largest trial (PPCOS II), ovulation occurred in about 62 percent of letrozole treatment cycles, and about 28 percent of women had a baby over up to five cycles, compared with about 19 percent on clomiphene. Multiple cycles may be needed.

For women with hypothalamic amenorrhea who address underlying factors, natural ovulation often returns. When gonadotropin treatment is needed, success rates are generally good.

For women with ovarian failure, treatment with own eggs is largely unsuccessful, but donor egg IVF has high success rates.

Questions to Ask Your Doctor

If you have been diagnosed with an ovulation disorder, consider asking what type of ovulation disorder you have, what is causing it, what lifestyle changes might help, what medications are recommended and why, what the expected success rates are for treatment, how you will be monitored during treatment, and when you should consider moving to more intensive treatment if this does not work.

Sources

• NICE NG257: Fertility problems, management of female factor fertility problems (2026) (checked October 2026)
• NICE NG257: Investigation of fertility problems (2026) (checked October 2026)
• Teede et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS. Hum Reprod, 2023 (checked October 2026)
• Teede et al. 2018 International Evidence-based PCOS Guideline recommendations. Hum Reprod, 2018 (checked October 2026)
• Legro et al. Letrozole versus clomiphene for infertility in PCOS (PPCOS II). N Engl J Med, 2014 (checked October 2026)
• Wang et al. Treatment strategies for women with WHO group II anovulation: network meta-analysis. BMJ, 2017 (checked October 2026)
• WHO: Polycystic ovary syndrome fact sheet (2026) (checked October 2026)

Medical Disclaimer

This article provides general information about ovulation disorders. Diagnosis and treatment should be individualised based on your specific situation. Please consult with a qualified healthcare provider or fertility specialist for personalised guidance.